Diabetes, Metabolic Syndrome and Obesity
Technology, Treatments and Therapeutics
Section Editor(s):
Dr Halis Kaan Akturk, Medicine and Pediatrics, Barbara Davis Center for Diabetes, University of Colorado, Boulder, CO, USA
This section considers submissions on therapeutic approaches to diabetes, metabolic syndrome and obesity management, with a focus on clinical applications, treatment modalities, and technological advancements in patient care. This includes Continuous Glucose Monitoring (CGM), Automated Insulin Delivery (AID), smart insulin pens, insulin pumps, insulin therapy, oral antidiabetics, injectable diabetes medications and treatments for type 1 and type 2 diabetes in adults. This section emphasizes clinical trials and clinically relevant research that has direct application to patient care and real-world implementation. This section will not consider basic science or pre-clinical research without human clinical data.
Latest articles in Technology, Treatments and Therapeutics:
- 25 records -
Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review
Pizirtzidou E, Karagkounis C, Bellali T, Katsiki N, Kazakos K, Muzurović E, Minasidou E
Diabetes, Metabolic Syndrome and Obesity 2026, 19:598765
Published Date: 12 May 2026
The Diabetes Staging System (DSS): A Pilot Study Assessing Feasibility, Provider Engagement and Implementation Challenges of a Novel Staging System for Type 2 Diabetes
Dar MS, Zhang J, Ashline A, Kota S, Woolson S, Majette NT, Bosworth HB
Diabetes, Metabolic Syndrome and Obesity 2026, 19:556175
Published Date: 9 April 2026
Comparative Association of Basal and Basal-Prandial Insulin Regimens on Remnant Cholesterol and Lipid Profiles in Patients with Type 2 Diabetes Mellitus
Natsir RM, Halimah E, Diantini A, Levita J, Umar H
Diabetes, Metabolic Syndrome and Obesity 2026, 19:588522
Published Date: 12 March 2026
Systematic Review of Oral Carbohydrate Treatment for Non-Severe Hypoglycemia in Type 1 Diabetes: A Comparison of Insulin Management Systems
Prince NL, Lochnan HA, Shorr R, Garon-Mailer A, Sun CJ
Diabetes, Metabolic Syndrome and Obesity 2026, 19:568538
Published Date: 7 March 2026
A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management
Chen Q, Chen T, Lin W, Chen X
Diabetes, Metabolic Syndrome and Obesity 2026, 19:585436
Published Date: 10 February 2026
Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders
Qiao Y, Zhou F, Mao T, Gao L
Diabetes, Metabolic Syndrome and Obesity 2026, 19:559587
Published Date: 10 February 2026
Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens
Liu BCL, Hannah KL, Nemlekar PM, Green CR, Norman GJ
Diabetes, Metabolic Syndrome and Obesity 2026, 19:574769
Published Date: 5 February 2026
Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh
Selim S, Rahman MH, Mustari M, Mohiuddin SM, Ahammed A, Hannan MA, Sharifuzzaman M, Mahjabeen S, Saifuddin M, Rahman MM, Afsana F, Raunak AIB
Diabetes, Metabolic Syndrome and Obesity 2026, 19:576436
Published Date: 3 February 2026
GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:584052
Published Date: 3 February 2026
Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations
Yılmaz N, Bastemir M
Diabetes, Metabolic Syndrome and Obesity 2026, 19:584175
Published Date: 30 January 2026
Transition from Continuous Subcutaneous Insulin Infusion to IDeg-Based Regimens in Hospitalized T2DM Patients: A Single-Center Retrospective Analysis
Dong R, Gu L, Li H, Hu Y, Liu H, Kou X, Zhao Y, Zhao M, Shi B, Guo H, Qiang W
Diabetes, Metabolic Syndrome and Obesity 2026, 19:557994
Published Date: 13 January 2026
Systematic Review of Continuous Glucose Monitoring and Its Effect on Quality of Life in Type 2 Diabetes Mellitus
Dwiastuti A, Latarissa IR, Hidayat A, Halimah E, Lestari K
Diabetes, Metabolic Syndrome and Obesity 2026, 19:561759
Published Date: 8 January 2026
Revolutionizing Diabetes Care: From Tech to Therapeutics
Akturk HK, Waterman LA, Cobry EC
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4675-4682
Published Date: 20 December 2025
Impact of SGLT2 Inhibitors on Tumor Development Risk in Type 2 Diabetes: A Retrospective Cohort Study
Wang Y, Ding Y, Yan X, Yao J, Wang M, Li Z, Zhu Y
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4587-4596
Published Date: 15 December 2025
Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study
Sharifuzzaman M, Paul AK, Akteruzzaman M, Bhuiyan SH, Haider R, Sharker S, Sultana D, Alam KM, Abu Zafar S, Kashem MA, Abu Zahid M, Islam AN, Abedin MZ, Anar F, Hasan MF, Selim S, Islam S, Ahammed A, Hosen M, Qureshi NK, Hossain MA, Begum A, Afrooz F, Kobir AM, Akter F, Mustafa SJ, Rahman MM, Saifuddin M
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4465-4482
Published Date: 4 December 2025
Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Mellitus: An Umbrella Review of Systematic Reviews
Shabil M, Kasoj M, Sulthana H, Ullah A, Verma A, Sah R, Mehta R, Babaresh WM
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4423-4437
Published Date: 2 December 2025
Efficacy and Safety of Roflumilast versus Alpha-Lipoic Acid in Type 2 Diabetes with Neuropathy: A Comparative Clinical Study
Elsharab A, Nooh MZ, Matard RS, Mostafa TM, El-Afify DR
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4193-4210
Published Date: 13 November 2025
Advances in Stem Cell Therapy for Diabetic Foot Ulcers
Wang B, Zhao G, Zhang J, Chen W, Yang S, Sun Y
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4021-4034
Published Date: 29 October 2025
Long-Term Efficacy Trajectories of GLP-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis
Li Z, Han Z, Sun R, Xuan X, Huang C
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3611-3624
Published Date: 23 September 2025
Analysis of Predictive Factors for the Efficacy of Modified Three-Port Laparoscopic Sleeve Gastrectomy in Treating Type 2 Diabetes Mellitus
Xu Z, Zhang W, Chen S, Liu B, Sun Y
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3375-3385
Published Date: 9 September 2025
Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports
Natsir RM, Halimah E, Diantini A, Levita J
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3215-3236
Published Date: 3 September 2025
Comment on: “Relative Effectiveness and Safety of the GLP-1 Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics” [Letter]
Zhu H, Jin H, Wang B
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3149-3150
Published Date: 2 September 2025
Effects of Additional Chinese Herbal Medicines Treatment in Patients with Type 2 Diabetes Mellitus Combined with Stable Angina Pectoris: A Retrospective Cohort Study
Xu X, Yin S, Liu H, Zhao R, Cui W, Shao M, Yu H, Yan S, Fu Y
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3135-3148
Published Date: 31 August 2025
Continuous Glucose Monitoring During Recreational Diving in Type 1 Diabetes: Navigating Clinical and Technical Uncertainties
Popovic DS, Koufakis T, Patoulias D, Stoian AP, Papanas N
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3089-3092
Published Date: 27 August 2025
Investigating Real-World Stability and Sterility of in-Use Insulin-An Urgent Public Health Concern. In Sub-Saharan Africa
Kimaro E, Konje ET, Mori AT, Kidenya BR, Kaale E
Diabetes, Metabolic Syndrome and Obesity 2025, 18:3027-3030
Published Date: 22 August 2025
